MADRIGAL PHARMACEUTICALS, INC. MDGL
CIK 0001157601
Form 4 transactions dated Sep 1, 2023 to Sep 26, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $139.67M
- Sold
- $299.72M
Sep 1, 2023 – Sep 11, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2025-12-10 | FRIEDMAN PAUL A Director | Sale10b5-1 footnote | $13.69M 24,800 shares sold | 11.70% sold Direct holding | ▾ |
| 2025-12-10 | Taub Rebecca Director | Sale10b5-1 footnote | $10.30M 18,650 shares sold | 3.89% sold Direct holding | ▾ |
| 2025-12-04 | Sibold William John President and CEO · Director | Sale | $1.38M 2,400 shares sold | 1.57% sold Direct holding | ▾ |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale10b5-1 footnote | $2.41M 4,173 shares sold | 28.56% sold Direct holding | ▾ |
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale10b5-1 footnote | $1.08M 1,958 shares sold | 16.33% sold Direct holding | ▾ |
| 2025-11-13 | Levy Richard S Director | Sale10b5-1 footnote | $4.43M 8,500 shares sold | 28.62% sold Direct holding | ▾ |
| 2025-11-05 | BATE KENNETH Director | Sale | $8.03M 16,575 shares sold | 86.32% sold Direct holding | ▾ |
| 2025-09-09 | Sibold William John President and CEO · Director | Sale | $3.24M 7,279 shares sold | 6.63% sold Direct holding | ▾ |
| 2025-08-21 | Sibold William John President and CEO · Director | Sale10b5-1 footnote | $3.05M 7,616 shares sold | 6.49% sold Direct holding | ▾ |
| 2025-08-20 | BAKER JULIAN · BAKER FELIX · BAKER BROS. ADVISORS LP · Baker Brothers Life Sciences LP · 667, L.P. · Baker Bros. Advisors (GP) LLC Director | Purchase | $23.07M 59,901 shares bought | Unavailable Indirect holding | ▾ |
Showing 30 / 42 record groups in 2025. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 42 purchase / sale groups and 30 of 90 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"MDGL","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.